Recent Quotes (30 days)

You have no recent quotes
chg | %

Pacgen Life Science Corp  

(Public, CVE:PBS)   Watch this stock  
Find more results for CVE:PGA
0.0450
+0.0100 (28.57%)
Dec 7 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.05 - 0.05
52 week 0.03 - 0.09
Open 0.05
Vol / Avg. 3,000.00/14,096.00
Mkt cap 1.84M
P/E     -
Div/yield     -
EPS 0.00
Shares 52.52M
Beta -1.04
Inst. own     -

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin -70.75% -21.80%
Operating margin -85.90% -13.49%
EBITD margin - -12.00%
Return on average assets -7.25% -2.77%
Return on average equity -13.24% -6.69%
Employees 10 -
CDP Score - -

Address

701 West Georgia Street Suite 1500
VANCOUVER, BC V7Y 1C6
Canada
+1-604-4364388 (Phone)
+1-604-4364380 (Fax)

Website links

Description

Pacgen Life Science Corporation, formerly Pacgen Biopharmaceuticals Corporation, is a life sciences company focused on the commercialization of life sciences products and services. The Company has a worldwide license to develop and commercialize an antifungal called P113 (also called PAC-113). It has sublicensed its PAC-113 right to General Biologicals Corporation (GBC), which offers non-prescription over-the-counter (OTC) products containing PAC-113 in Taiwan. P113 is a 12 amino-acid antimicrobial peptide derived from a histatin protein found in saliva. Its P113 is used for the treatment of various oral conditions, as well as vaginal, dermatological and ophthalmic conditions. GBC offers products, such as cosmetic skin-care products, oral hygiene products and intimate hygiene products. The oral healthcare product includes Mr.&Mrs.O. It has conducted a Phase IIb dose-ranging clinical trial for PAC-113. Its oral health and woman health products are in the commercialization stage.

Officers and directors

Chung-Yu Wang Chairman of the Board, Chief Executive Officer
Christina Yip President, Chief Financial Officer, Director
Telvin Ju Ph.D. Lead Independent Director
Alan C. Savage Director
Jeng-Horng Her Ph.D. Independent Director
Min-Chih Hsuan Independent Director
Age: 60
Frederick Huang Independent Director